Left ventricular cardiac hemangioma in a patient with chronic heart failure.

J Med Ultrason (2001)

Department of Internal Medicine, Osaka Minato Central Hospital, 8-31 Chikko, Minato-ku, Osaka, 552-0021, Japan.

Published: July 2018

Cardiac hemangiomas are rare benign tumors. Here, we report the case of a man in his 30s who had a cardiac hemangioma with no symptoms. He was being treated with β-blockers for chronic heart failure with hypertensive heart disease at Osaka Minato Central Hospital. Routine echocardiography revealed a mobile spherical mass in the left ventricle that had not been detected on echocardiography performed 4 months previously. Subsequently, the tumor was excised to prevent potential embolic events and was pathologically diagnosed as a cardiac hemangioma. This case demonstrates the relatively rapid progress of a cardiac hemangioma regardless of β-blocker administration, which is occasionally used for the treatment of hemangiomas. The efficacy of β-blockers in treating cardiac hemangiomas may vary according to the type of β-blocker. Echocardiography is useful in screening and follow-up of cardiac hemangiomas; however, additional imaging modalities are needed for differential diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10396-017-0852-zDOI Listing

Publication Analysis

Top Keywords

cardiac hemangioma
16
cardiac hemangiomas
12
chronic heart
8
heart failure
8
cardiac
7
left ventricular
4
ventricular cardiac
4
hemangioma
4
hemangioma patient
4
patient chronic
4

Similar Publications

Background: Lung transplantation is a viable lifesaving option for patients with diffuse pulmonary arteriovenous malformations (AVMs). We present a case of diffuse pulmonary AVMs associated with juvenile polyposis and hereditary hemorrhagic telangiectasia (JP-HHT) that was successfully managed by lung transplantation.

Case Presentation: A 19-year-old woman developed severe hypoxemia due to pulmonary AVMs diagnosed at 4 years of age.

View Article and Find Full Text PDF

Macrophage Ferroptotic Resistance Is Required for the Progression of Infantile Hemangioma.

J Am Heart Assoc

January 2025

State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology Wuhan University Wuhan China.

Article Synopsis
  • Ferroptosis is a form of programmed cell death linked to iron and lipid peroxides, and this study explores its role in infantile hemangioma (IH).
  • Involutive IH samples showed significantly higher levels of ferroptotic markers and increased expression of GPX4, an enzyme that helps resist ferroptosis, compared to proliferative samples.
  • Hemangioma-derived stem cells (HemSCs) enhance GPX4 expression in macrophages, promoting their resistance to ferroptosis, which is essential for the development of IH.
View Article and Find Full Text PDF

Background: There is a paucity of studies on patient-reported outcomes and quality of life (QoL) in conservatively managed patients with a cerebral cavernous malformation (CCM).

Methods: This single-center observational study included consecutive adult CCM patients, diagnosed in 2000-2023, managed conservatively, and with at least 6 months of follow-up. Patients completed two validated patient-reported outcome measures (PROMs): EuroQol 5-dimensions 5-levels (EQ-5D-5L), and Patient-Reported Outcome Measurement Information System 29 (PROMIS-29).

View Article and Find Full Text PDF

It has been claimed that microRNA 503-5p (miR-503-5p) is the key to the future diagnosis and treatment of cardiac hemangioma (CH), but the relationship between the two has not been fully validated. In this study, we analyzed the effect of miR-503-5p targeting type IA bone morphogenetic protein receptor (BMPR1A) on CH to inform future diagnosis and treatment of CH. First, miR-503-5p and BMPR1A abnormal expression sequences (vectors) were transfected into human hemangioma-derived endothelial cells (HemECs) and human umbilical vein endothelial cells (HUVECs) to observe alterations in cell biological behavior, adhesion, and epithelial mesenchymal transition (EMT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!